TP53 and myelodysplastic syndrome: In the third patient with MDS, the malignant clone did not arise from ATM-mutant cells; their progression to MDS was accompanied by the expansion of a TP53-mutated clone, while the VAFs of both somatic ATM variants diminished (Figure 11H).